J 2024

Clinical and genomic diversity of Treponema pallidum subspecies pallidum to inform vaccine research: an international, molecular epidemiology study

SEÑA, Arlene C; Mitch M MATOGA; Ligang YANG; Eduardo LOPEZ-MEDINA; Farhang AGHAKHANIAN et. al.

Základní údaje

Originální název

Clinical and genomic diversity of Treponema pallidum subspecies pallidum to inform vaccine research: an international, molecular epidemiology study

Autoři

SEÑA, Arlene C; Mitch M MATOGA; Ligang YANG; Eduardo LOPEZ-MEDINA; Farhang AGHAKHANIAN; Jane S CHEN; Everton B BETTIN; Melissa J CAIMANO; Wentao CHEN; Jonny A GARCIA-LUNA; Christopher M HENNELLY; Edward JERE; Yinbo JIANG; Jonathan J JULIANO; Petra POSPÍŠILOVÁ; Lady RAMIREZ; David ŠMAJS; Joseph D TUCKER; Fabio Vargas CELY; Heping ZHENG; Irving F HOFFMAN; Bin YANG; M Anthony MOODY; Kelly L HAWLEY; Juan C SALAZAR; Justin D RADOLF a Jonathan B PARR

Vydání

The Lancet Microbe, AMSTERDAM, ELSEVIER, 2024, 2666-5247

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Stát vydavatele

Nizozemské království

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Organizace

Lékařská fakulta – Masarykova univerzita – Repozitář

UT WoS

001309314400001

EID Scopus

2-s2.0-85202484681

Klíčová slova anglicky

Treponema pallidum; clinical diversity; genomic diversity

Návaznosti

LX22NPO5103, projekt VaV.
Změněno: 24. 9. 2024 00:50, RNDr. Daniel Jakubík

Anotace

V originále

Background The increase in syphilis rates worldwide necessitates development of a vaccine with global efficacy. We aimed to explore Treponema pallidum subspecies pallidum (TPA) molecular epidemiology essential for vaccine research by analysing clinical data and specimens from early syphilis patients using whole-genome sequencing (WGS) and publicly available WGS data. Methods In this multicentre, cross-sectional, molecular epidemiology study, we enrolled patients with primary, secondary, or early latent syphilis from clinics in China, Colombia, Malawi, and the USA between Nov 28, 2019, and May 27, 2022. Participants aged 18 years or older with laboratory confirmation of syphilis by direct detection methods or serological testing, or both, were included. Patients were excluded from enrolment if they were unwilling or unable to give informed consent, did not understand the study purpose or nature of their participation, or received antibiotics active against syphilis in the past 30 days. TPA detection and WGS were conducted on lesion swabs, skin biopsies, skin scrapings, whole blood, or rabbit-passaged isolates. We compared our WGS data to publicly available genomes and analysed TPA populations to identify mutations associated with lineage and geography. Findings We screened 2802 patients and enrolled 233 participants, of whom 77 (33%) had primary syphilis, 154 (66%) had secondary syphilis, and two (1%) had early latent syphilis. The median age of participants was 28 years (IQR 22–35); 154 (66%) participants were cisgender men, 77 (33%) were cisgender women, and two (1%) were transgender women. Of the cisgender men, 66 (43%) identified as gay, bisexual, or other sexuality. Among all participants, 56 (24%) had HIV co-infection. WGS data from 113 participants showed a predominance of SS14-lineage strains with geographical clustering. Phylogenomic analyses confirmed that Nichols-lineage strains were more genetically diverse than SS14-lineage strains and clustered into more distinct subclades. Differences in single nucleotide variants (SNVs) were evident by TPA lineage and geography. Mapping of highly differentiated SNVs to three-dimensional protein models showed population-specific substitutions, some in outer membrane proteins (OMPs) of interest. Interpretation Our study substantiates the global diversity of TPA strains. Additional analyses to explore TPA OMP variability within strains is vital for vaccine development and understanding syphilis pathogenesis on a population level.

Přiložené soubory